The Covid pandemic has struck particularly hard at older Americans, with most of the deaths from Covid concentrated in those over 65 years of age, especially if they had co-morbid conditions. Many of the risk factors for SARS-CoV2 are also risk factors for Alzheimer’s disease (AD). A new article in the Journal of Alzheimer’s Disease by the world’s experts in the field of Alzheimer’s and Covid reveals the latest research and news on brain health.
The authors of this article looked at the medical records of over 6 million people and discovered that people who had Covid are at significant risk for Alzheimer’s. It’s especially concerning for people who have what they call “Long Covid” where brain fatigue, trouble concentrating, sleep problems, and other mental issues are seen. Luckily for us, we have the opportunity to hear from the authors of the paper, including the former dean of the medical school at Case Western University, during our webinar on December 8th.
In this program, we will discuss the relationships between Covid and AD, including the susceptibility, outcomes and disparities of Covid associated with AD during the early phase of the pandemic, the risk of breakthrough infection and associated outcomes following vaccination against Covid, and the risk of new diagnosis of AD in the year following infection with Covid.
This program will discuss their findings and how it might be interpreted, as well as the necessary studies to follow up this observation.
The New Covid-Alzheimer's Connection
Thursday, December 8th, 2022
4 pm PT / 5 pm MT / 6 pm CT / 7 pm ET
Duration: 60 minutes
Guest Speakers: Pamela B. Davis, MD, PhD and Rong Xu, PhD, FACMI
Host: Christopher Walling, PSY.D, MBA, C-IAYT, SEP
Please join us on Thursday, December 8th for this exceptional discussion on how Covid affects cognition.
You will also receive the recording after.
Learning Objectives:
- Identify important risk factors for the development of Alzheimer’s disease
- Discuss the risk for SARS-CoV2 infection in patients with Alzheimer’s disease
- Describe the association between Covid and the development of Alzheimer’s disease
- Discuss the negative cognitive effects of Covid
- Discuss potential treatments of long Covid in patients with Alzheimer’s disease
The New Covid-Alzheimer's Connection
Thursday, December 8th, 2022
4 pm PT / 5 pm MT / 6 pm CT / 7 pm ET
Duration: 60 minutes
Guest Speakers: Pamela B. Davis, MD, PhD and Rong Xu, PhD, FACMI
Hosts: Christopher Walling, PSY.D, MBA, C-IAYT, SEP
About the Speakers:
Pamela B. Davis, MD, PhD
Arline H. and Curtis F. Garvin Research Professor and Professor, Center for Community Health Integration, Distinguished University Professor, Case Western Reserve University School of Medicine
Following a 30-year career as a physician-scientist working in cystic fibrosis, Pamela B. Davis, MD, PhD, became dean of the School of Medicine and senior vice president for medical affairs at Case Western Reserve University in 2007. She stepped down in 2020 to begin a new research career in bioinformatics. During her time as dean she was an active supporter of the new Western Reserve 2 medical school curriculum, improved the commercialization of research discoveries in the School, and greatly expanded activities in support of the health of the community. She served for two cycles as the principal investigator of the NIH’s CTSA award, and has championed the discipline of broadly engaged team science. During her career, Davis has been inducted into the National Academy of Medicine and the National Academy of Inventors, served on the Advisory Councils of NIDDK and NCATS and the Board of Scientific Counselors of NHLBI.
Rong Xu, PhD, FACMI
Professor of Biomedical Informatics, Director of Center for Artificial Intelligence in Drug Discovery, Case Western Reserve University School of Medicine
Dr. Xu earned her BS degree in Biology from Peking University, M.S degree in Biology from Case Western Reserve University, M.S in Computer Science and Ph.D. in Biomedical Informatics both from Stanford University. Dr. Xu’s research falls into two broad categories: theoretical computer algorithm development and translational biomedical research. Her research interests in computer science focus on artificial intelligence, natural language processing, machine learning, data mining, statistical learning, systems biology, and other advanced computational techniques that can create, integrate, and analyze large amounts of heterogeneous and complex biological and health data. Her research interests in biomedical sciences include drug discovery, disease gene discovery, precision medicine, and health outcomes research. Dr. Xu has received several prestigious awards: (1) elected Fellow of American College of Medical Informatics; (2) The NIH Director’s New Innovator Award, (3) the Landon-AACR (American Association for Cancer Research) Innovator Award for Cancer Prevention Research, (4) the AMIA (American Medical Informatics Association) New Investigator award. Her research works in COVID-19 in vulnerable population including patients with Alzheimer’s disease have been included in the CDC guidelines, reached tens of millions of twitters, and featured in > 1000 news including New York Times, NPR, ABC news, NBC news, Forbes, USA Today, Fox News and Scientific Americans.
Christopher Walling, PSY.D, MBA, C-IAYT, SEP
Adjunct Professor, Somatic Psychology, California Institute for Integral Studies, San Francisco, CA, USA
Dr. Walling is a licensed clinical psychologist, researcher and an active leader in the biobehavioral sciences. His work in academic medicine has included the administration of multidisciplinary leadership teams in hematology-oncology, physical medicine and rehabilitation, and geriatric psychiatry at some of the top academic medical centers in the United States. His clinical focus in the behavioral sciences has examined the intersections of neuro-psychotherapy, affect regulation, and psychophysiology. Dr. Walling is an Adjunct Professor of Somatic Psychology at the California Institute of Integral Studies, Past-President of the United States Association for Body Psychotherapy, and an Associate Deputy-Editor of the International Body Psychotherapy Journal. He is a Clinical Supervisor at the Wright Institute of Los Angeles, a Clinical Associate at the New Center for Psychoanalysis, and is a Clinical Research Fellow at the Traumatic Stress Research Consortium located at Indiana University where he and his colleagues are working to advance scientific insights from trauma psychology. Dr. Walling maintains a private practice in Los Angeles, California.
Can’t attend in person? No problem. This webinar will be recorded and sent to you a few days later. The link for Zoom video access will be sent out in the confirmation email after registration is completed.
Important: Please add admin@arpf.com to your contact list so no communication gets lost in spam.
This webinar is part of ARPF's fundraising initiative. Your registration fee supports programs of ARPF. We thank you for supporting our mission.
We also accept PayPal. Please contact Chelsea to make arrangements chelsea@alzheimersprevention.org
